3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Colorectal Neoplasms
4
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Motor Activity
2
Lung Neoplasms
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Trastuzumab Cardiotoxicity
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Insulin Resistance
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Diseases
1
Fatigue
1
Esophageal Neoplasms
1
Dyslipidemias
1
Depression
1
Interventions
Metformin
91
Clomiphene
31
Letrozole
23
Inositol
19
Folic Acid
11
Chorionic Gonadotropin
11
Exercise
10
High-Intensity Interval Training
9
drospirenone and ethinyl estradiol combination
8
Ethinyl Estradiol
8
Contraceptives, Oral
8
Cholecalciferol
8
cetrorelix
7
Tablets
7
Progesterone
7
Menotropins
6
follitropin alfa
5
Pioglitazone
5
Liraglutide
5
Exenatide
5
Cyproterone Acetate
5
Caloric Restriction
5
Vitamin D
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Sugars
4
Spironolactone
4
Glycoprotein Hormones, alpha Subunit
4
Fish Oils
4
Estradiol
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycystic Ovary Syndrome
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled